Unknown

Dataset Information

0

BIDIMENSIONAL LINKED MATRIX FACTORIZATION FOR PAN-OMICS PAN-CANCER ANALYSIS.


ABSTRACT: Several modern applications require the integration of multiple large data matrices that have shared rows and/or columns. For example, cancer studies that integrate multiple omics platforms across multiple types of cancer, pan-omics pan-cancer analysis, have extended our knowledge of molecular heterogeneity beyond what was observed in single tumor and single platform studies. However, these studies have been limited by available statistical methodology. We propose a flexible approach to the simultaneous factorization and decomposition of variation across such bidimensionally linked matrices, BIDIFAC+. BIDIFAC+ decomposes variation into a series of low-rank components that may be shared across any number of row sets (e.g., omics platforms) or column sets (e.g., cancer types). This builds on a growing literature for the factorization and decomposition of linked matrices which has primarily focused on multiple matrices that are linked in one dimension (rows or columns) only. Our objective function extends nuclear norm penalization, is motivated by random matrix theory, gives a unique decomposition under relatively mild conditions, and can be shown to give the mode of a Bayesian posterior distribution. We apply BIDIFAC+ to pan-omics pan-cancer data from TCGA, identifying shared and specific modes of variability across four different omics platforms and 29 different cancer types.

SUBMITTER: Lock EF 

PROVIDER: S-EPMC9060567 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

BIDIMENSIONAL LINKED MATRIX FACTORIZATION FOR PAN-OMICS PAN-CANCER ANALYSIS.

Lock Eric F EF   Park Jun Young JY   Hoadley Katherine A KA  

The annals of applied statistics 20220328 1


Several modern applications require the integration of multiple large data matrices that have shared rows and/or columns. For example, cancer studies that integrate multiple omics platforms across multiple types of cancer, <i>pan-omics pan-cancer analysis</i>, have extended our knowledge of molecular heterogeneity beyond what was observed in single tumor and single platform studies. However, these studies have been limited by available statistical methodology. We propose a flexible approach to t  ...[more]

Similar Datasets

| S-EPMC6309559 | biostudies-literature
| S-EPMC10243929 | biostudies-literature
| S-EPMC8796362 | biostudies-literature
| S-EPMC9387871 | biostudies-literature
| S-EPMC3655687 | biostudies-literature
| S-EPMC5006236 | biostudies-literature
| S-EPMC10766378 | biostudies-literature
| S-EPMC11924690 | biostudies-literature
| S-EPMC6697569 | biostudies-literature
| S-EPMC4579132 | biostudies-literature